Purine auxotrophy: Possible applications beyond genetic marker

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Traditional treatments are losing efficacy against diseases like cancer and protozoan infections.
• Cell purine metabolism is a conserved pathway across eukaryotes, making it a potential drug target.
• Some organisms, including certain cancer cells and parasitic protozoans, are purine auxotrophs, relying on external purine sources.

Purpose of the Study:

• To review the principles of eukaryotic purine metabolism and the effects of purine starvation.
• To highlight the utility of purine-starved Saccharomyces cerevisiae as a model for studying metabolic states induced by purine depletion.
• To explore applications in evolution studies and pharmacology, particularly for identifying new therapeutic strategies.

Main Methods:

• Review of existing literature on eukaryotic purine metabolism.
• Analysis of purine metabolism in Saccharomyces cerevisiae, focusing on auxotrophic strains.
• Comparison of metabolic states in purine-starved yeast with those in parasitic protozoans and cancer cells.

Main Results:

• Purine auxotrophic yeast strains exhibit distinct behaviors under adenine starvation, including cell cycle arrest at G1/G0 and enhanced stress resistance.
• These observed effects in yeast are analogous to changes seen in parasitic protozoans and cancer cells.
• Purine starvation induces specific metabolic states that can be modeled using yeast.

Conclusions:

• Studies on metabolic changes due to purine auxotrophy offer potential for novel parasite and cancer therapies.
• Understanding these phenotypic changes can improve the use of auxotrophic strains in high-throughput drug screening.
• Purine metabolism represents a promising target for developing new drugs against various diseases.